When assessing whether an HCC multidisciplinary clinic is improving outcomes beyond stage migration, which patient-level, clinically actionable metrics do you track (e.g., time-to-treatment, guideline-concordant therapy, successful bridging/downstaging, treatment sequencing changes)?